Cotton price action is down 166 to 224 points across the front months on Tuesday morning. Futures were up 4 to 71 points across the board at the close. Crude oil was up 88 cents per barrel on the session, with the US dollar index $0.232 higher. Weekly Crop Progress...
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 24, DoubleLine Yield Opportunities Fund's Vice President, Jeffrey J. Sherman, invested $130,300.00 into 10,000 shares of DLY,
(RTTNews) - Metallus Inc.(MTUS), a maker of alloy steel, carbon and micro-alloy steel products, said on Tuesday that it has secured a contract to supply steel for critical defense applications.
(RTTNews) - Tuesday, CSL Seqirus, a business of CSL (CSL.AX), said it has expanded the availability of influenza vaccines in the U.S. following the successful completion of its 2026/27 manufacturing campaign.
(RTTNews) - Immix Biopharma (IMMX), on Tuesday reported that an interim update from the Phase 2 NEXICART-2 study showed an 89% complete response (CR) rate with investigational NXC-201 in patients with relapsed/refractory AL amyloidosis.
(RTTNews) - uniQure (QURE) reported additional data from its ongoing Phase I/II studies of ifezuntirgene inilparvovec (AMT-130) for the treatment of Huntington's disease.
(RTTNews) - Unicycive Therapeutics (UNCY) has resubmitted its New Drug Application (NDA) for oxylanthanum carbonate, seeking FDA approval of the oral phosphate binder for hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.
(RTTNews) - Pearson plc (PSO, PSON.L), a British learning and skill enterprise company, on Tuesday said it has agreed to acquire Workera, an AI intelligence platform focused on enterprise assessment and skills verification.
(RTTNews) - AT&T Inc. (T) on Tuesday said it has entered into a multi-year agreement with materials science company Corning Inc. (GLW), valued at more than $3 billion, for the supply of fiber and cable to support its network expansion and growing data demand.
(RTTNews) - Biotechnology company Unicycive Therapeutics, Inc. (UNCY) announced Tuesday the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company's investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with
(RTTNews) - Tuesday, uniQure (QURE) reported new data showing its investigational gene therapy AMT-130 continued to slow measures of Huntington's disease progression in patients followed for up to 48 months.
(RTTNews) - Tuesday, Kyowa Kirin (4151.T) said it entered into an exclusive distribution agreement with Knight Therapeutics (GUD.TO) for POTELIGEO (mogamulizumab) in select Latin American countries.